Equity Method Investments (Tables)

12 Months Ended

Mar. 31, 2021

Equity Method Investments And Joint Ventures [Abstract]

Summary of Changes in Investments in Associates that are Accounted for Using Equity Method

The following tables present changes in the Company’s investments in associates that are accounted for using the equity method in the years ended March 31, 2021 and 2020:

			Balance at		Share of									Derecognition			Balance at
		Ownership	March 31,		net (loss)			Impairment			Derecognition			of RIV			March 31,
Entity	Instrument	percentage	2020		income			losses			of investment			Capital1			2021
PharmHouse2	Shares	49%	$	37,025	$	(4,656	)	$	(32,369	)	$	-		$	-		$	-
More Life	Shares	40%		10,300		-			(10,300	)		-			-			-
CanapaR	Shares	49%		8,500		(500	)		-			(8,000	)					-
Other	Shares	18%-40%		10,018		(3,326	)		(1,478	)		-			(5,114	)		100
				65,843		(8,482	)		(44,147	)		(8,000	)		(5,114	)		100

¹Refer to Note 6 for information regarding the completion of the plan of arrangement with RIV Capital.

²Refer to Note 12 for information regarding PharmHouse.

			Balance at				Share									Balance at
		Ownership	March 31,				of net			Impairment			Derecognition			March 31,
Entity	Instrument	percentage	2019		Additions		loss			losses			of investment			2020
PharmHouse	Shares	49%	$	39,278	$	-	$	(2,253	)	$	-		$	-		$	37,025
Agripharm	Shares	40%		36,127		-		(1,963	)		(29,164	)		-			5,000
More Life	Shares	40%		-		25,200		-			(14,900	)		-			10,300
CanapaR	Shares	49%		18,062		-		(1,386	)		(8,176	)		-			8,500
BCT	Shares	47%		11,653		-		(385	)		-			(11,268	)		-
Other	Shares	18%-27%		7,265		5,135		(3,207	)		(2,986	)		(1,189	)		5,018
			$	112,385	$	30,335	$	(9,194	)	$	(55,226	)	$	(12,457	)	$	65,843

Summary of Derecognized Assets and Liabilities

Following this transaction, the Company no longer controlled 1955625 Ontario Inc. and the Company derecognized the assets and liabilities of 1955625 Ontario Inc. from its consolidated financial statements at their carrying amounts. Management has concluded that the subsidiary does not meet the definition of an operation and no goodwill was allocated. The derecognized assets and liabilities on November 7, 2019, were as follows:

Current assets	$	100
Intangible assets		2,810
Net assets disposed	$	2,910
Fair value of retained interest		25,200
Gain on disposal of consolidated entity	$	22,290

Summary of Financial Information of Equity Method Investments

The following tables present current and non-current assets, current and non-current liabilities as well as revenues and net loss of the Company’s equity method investments as at and for the years ended December 31, 2020 and 2019, respectively:

	Current		Non-current		Current		Non-current
Entity	assets		assets		liabilities		liabilities		Revenue		Net loss
Other	$	4,895	$	25,051	$	29,830	$	1,605	$	3,705	$	(10,033	)

	Current		Non-current		Current		Non-current
Entity	assets		assets		liabilities		liabilities		Revenue		Net loss
PharmHouse	$	5,584	$	163,888	$	65,765	$	87,659	$	219	$	(4,665	)
Agripharm		9,565		68,608		25,776		-		5,093		(8,668	)
CanapaR		15,232		10,277		1,722		-		425		(2,624	)
Other		10,980		22,338		3,187		10,600		7,022		(10,322	)
	$	41,361	$	265,111	$	96,450	$	98,259	$	12,759	$	(26,279	)